These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21761770)

  • 21. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
    Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
    Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
    Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
    Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
    Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
    Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.
    Iba T
    Crit Care; 2015 May; 19(1):233. PubMed ID: 26002185
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT.
    Nakamura D; Yoshimitsu M; Kawada H; Inoue H; Kuroki T; Kaieda T; Fujino S; Hamada H; Suzuki S; Matsushita K; Uozumi K; Arima N
    Bone Marrow Transplant; 2012 Mar; 47(3):463-4. PubMed ID: 21552299
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial.
    Aikawa N; Shimazaki S; Yamamoto Y; Saito H; Maruyama I; Ohno R; Hirayama A; Aoki Y; Aoki N
    Shock; 2011 Apr; 35(4):349-54. PubMed ID: 21068698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recombinant thrombomodulin].
    Maruyama I; Okadome T; Yamamoto S
    Rinsho Byori; 1990 Jul; Suppl 86():194-8. PubMed ID: 2172595
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
    Maruyama I
    Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.
    Levi M
    J Thromb Haemost; 2015 Apr; 13(4):505-7. PubMed ID: 25650725
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thrombosis and DIC in hematological malignancies].
    Asakura H
    Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Roles of thrombomodulin as a nuclear safeguard].
    Ito T
    Nihon Yakurigaku Zasshi; 2014 Jan; 143(1):18-21. PubMed ID: 24420132
    [No Abstract]   [Full Text] [Related]  

  • 34. Pleiotropic effects of thrombomodulin in the management of DIC.
    Ito T; Maruyama I
    Rinsho Ketsueki; 2011 Jun; 52(6):356-60. PubMed ID: 21737987
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The cutting-edge of medicine; diagnostic criteria for disseminated intravascular coagulation (DIC) and therapeutic findings].
    Nomura S
    Nihon Naika Gakkai Zasshi; 2013 Jan; 102(1):153-9. PubMed ID: 23777128
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC.
    Ikezoe T; Ikenoue N; Uchikawa N; Kojima S; Fukaya T; Yokoyama A
    Thromb Res; 2010 Sep; 126(3):e238-40. PubMed ID: 20627281
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin.
    Sakai M; Ikezoe T; Bandobashi K; Yokoyama A
    Thromb Res; 2010 Nov; 126(5):e392-3. PubMed ID: 20656332
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of DIC associated with myelogenous leukemia].
    Sakata Y
    Nihon Rinsho; 2009 Oct; 67(10):1978-83. PubMed ID: 19860201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ART-123 Asahi Kasei.
    Khorchidi S; Bantleon R; Kehlbach R; Tepe G; Wiskirchen J; Duda SH
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1196-8. PubMed ID: 12211414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.